BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10822219)

  • 1. Somatic trinucleotide change encompassing codons 882 and 883 of the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma.
    Bugalho MJ; Coelho I; Sobrinho LG
    Eur J Endocrinol; 2000 Jun; 142(6):573-5. PubMed ID: 10822219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma.
    Marsh DJ; Learoyd DL; Andrew SD; Krishnan L; Pojer R; Richardson AL; Delbridge L; Eng C; Robinson BG
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):249-57. PubMed ID: 8729519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single missense mutation in codon 918 of the RET proto-oncogene in sporadic medullary thyroid carcinomas.
    Maeda S; Namba H; Takamura N; Tanigawa K; Takahashi M; Noguchi S; Nagataki S; Kanematsu T; Yamashita S
    Endocr J; 1995 Apr; 42(2):245-50. PubMed ID: 7627269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three novel mutations in the RET proto-oncogene.
    Kalinin VN; Amosenko FA; Shabanov MA; Lubchenko LN; Hosch SB; Garkavtseva RF; Izbicki JR
    J Mol Med (Berl); 2001 Oct; 79(10):609-12. PubMed ID: 11692159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
    Romei C; Elisei R; Pinchera A; Ceccherini I; Molinaro E; Mancusi F; Martino E; Romeo G; Pacini F
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1619-22. PubMed ID: 8636377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel point mutations and allele loss at the RET locus in sporadic medullary thyroid carcinomas.
    Uchino S; Noguchi S; Adachi M; Sato M; Yamashita H; Watanabe S; Murakami T; Toda M; Murakami N; Yamashita H
    Jpn J Cancer Res; 1998 Apr; 89(4):411-8. PubMed ID: 9617347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mutations in RET exons 12 and 15 in sporadic medullary thyroid carcinomas: different spectrum of mutations in sporadic type from hereditary type.
    Uchino S; Noguchi S; Yamashita H; Sato M; Adachi M; Yamashita H; Watanabe S; Ohshima A; Mitsuyama S; Iwashita T; Takahashi M
    Jpn J Cancer Res; 1999 Nov; 90(11):1231-7. PubMed ID: 10622534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion-insertion mutation encompassing RET codon 634 is associated with medullary thyroid carcinoma.
    Marsh DJ; Andrew SD; Learoyd DL; Pojer R; Eng C; Robinson BG
    Hum Mutat; 1998; Suppl 1():S3-4. PubMed ID: 9452023
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular analysis of the RET proto-oncogene in patients with sporadic medullary thyroid carcinoma: a novel point mutation in the extracellular cysteine-rich domain.
    Bugalho MJ; Frade JP; Santos JR; Limbert E; Sobrinho L
    Eur J Endocrinol; 1997 Apr; 136(4):423-6. PubMed ID: 9150704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
    Fink M; Weinhüsel A; Niederle B; Haas OA
    Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma.
    Eng C; Mulligan LM; Smith DP; Healey CS; Frilling A; Raue F; Neumann HP; Ponder MA; Ponder BA
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):123-7. PubMed ID: 7641404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A complex nine base pair deletion in RET exon 11 common in sporadic medullary thyroid carcinoma.
    Alemi M; Lucas SD; Sällström JF; Bergholm U; Akerström G; Wilander E
    Oncogene; 1997 May; 14(17):2041-5. PubMed ID: 9160884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A.
    Berndt I; Reuter M; Saller B; Frank-Raue K; Groth P; Grussendorf M; Raue F; Ritter MM; Höppner W
    J Clin Endocrinol Metab; 1998 Mar; 83(3):770-4. PubMed ID: 9506724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel somatic mutation in the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma.
    Matias-Guiu X; Lagarda E; Calaf M; Azpiroz A; De Leiva A; Prat J; Baiget M
    Hum Mutat; 1997; 9(5):476. PubMed ID: 9143934
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas.
    Komminoth P; Kunz EK; Matias-Guiu X; Hiort O; Christiansen G; Colomer A; Roth J; Heitz PU
    Cancer; 1995 Aug; 76(3):479-89. PubMed ID: 8625130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The newly detected mutations in the RET proto-oncogene in exon 16 as a cause of sporadic medullary thyroid carcinoma.
    Jindrichova S; Kodet R; Krskova L; Vlcek P; Bendlova B
    J Mol Med (Berl); 2003 Dec; 81(12):819-23. PubMed ID: 14618242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RET protooncogene mutations in patients with apparently sporadic medullary thyroid carcinoma.
    Huang CN; Wu SL; Chang TC; Huang SH; Chang TJ
    J Formos Med Assoc; 1998 Aug; 97(8):541-6. PubMed ID: 9747064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel somatic mutation in the RET proto-oncogene in familial medullary thyroid carcinoma with a germline codon 768 mutation.
    Miyauchi A; Egawa S; Futami H; Kuma K; Obara T; Yamaguchi K
    Jpn J Cancer Res; 1997 Jun; 88(6):527-31. PubMed ID: 9263528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.
    Eng C; Smith DP; Mulligan LM; Healey CS; Zvelebil MJ; Stonehouse TJ; Ponder MA; Jackson CE; Waterfield MD; Ponder BA
    Oncogene; 1995 Feb; 10(3):509-13. PubMed ID: 7845675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.